Louis Chen
Stock Analyst at Scotiabank
(0.08)
# 4,576
Out of 5,245 analysts
11
Total ratings
18.18%
Success rate
-45.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Maintains: Sector Outperform | $140 → $177 | $134.36 | +31.74% | 2 | Feb 11, 2026 | |
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $3.98 | - | 8 | Sep 10, 2024 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $47.30 | +16.28% | 1 | Feb 24, 2022 |
Gilead Sciences
Feb 11, 2026
Maintains: Sector Outperform
Price Target: $140 → $177
Current: $134.36
Upside: +31.74%
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $3.98
Upside: -
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $47.30
Upside: +16.28%